Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viking Therapeutics (VKTX) Non-cash Items (2016 - 2025)

Historic Non-cash Items for Viking Therapeutics (VKTX) over the last 11 years, with Q3 2025 value amounting to $2.9 million.

  • Viking Therapeutics' Non-cash Items rose 4785.39% to $2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.9 million, marking a year-over-year increase of 4785.39%. This contributed to the annual value of $141.3 million for FY2024, which is 561649.7% up from last year.
  • As of Q3 2025, Viking Therapeutics' Non-cash Items stood at $2.9 million, which was up 4785.39% from $2.9 million recorded in Q2 2025.
  • Viking Therapeutics' 5-year Non-cash Items high stood at $23.3 billion for Q3 2023, and its period low was $1.4 million during Q1 2022.
  • Over the past 5 years, Viking Therapeutics' median Non-cash Items value was $3.0 million (recorded in 2023), while the average stood at $1.4 billion.
  • Per our database at Business Quant, Viking Therapeutics' Non-cash Items surged by 79758148.6% in 2023 and then crashed by 9999.15% in 2024.
  • Over the past 5 years, Viking Therapeutics' Non-cash Items (Quarter) stood at $2.9 billion in 2021, then plummeted by 99.29% to $20.5 million in 2022, then surged by 203.24% to $62.2 million in 2023, then skyrocketed by 127.13% to $141.3 million in 2024, then tumbled by 97.92% to $2.9 million in 2025.
  • Its Non-cash Items was $2.9 million in Q3 2025, compared to $2.9 million in Q2 2025 and $66.4 million in Q1 2025.